Back to Media Room
 
New Straits Time, June 20, 2008

RM450m biotech boost for Malacca

From Shahriman Johari

SAN DIEGO: Vivo Bio Malaysia Sdn Bhd, a subsidiary of India's Vivo Bio Tech Ltd, will spend RM450 million to build a contract research and manufacturing facility in Malacca.

It will be doing work for pharmaceutical companies that are developing drugs to treat cancer and diabetes, among other illnesses.

The investment is set to be Malacca's biggest in biotechnology thus far.

"This is a world-scale-size facility," said Datuk Kuna Sittampalam, director of Vivo Bio Tech. Kuna, a Malaysian, holds 15 per cent of Vivo Bio Tech, which is listed on the Bombay Stock Exchange.

Vishwanath Komplella, chairman of Vivo Bio Tech, expects the plant to be ready for operation by the end of 2010 as construction is due to start at the end of this year.

"We are moving at an amazing speed. We have done initial layouts and we are close to the finalisation of drawings," he told Malaysian reporters at a briefing on the sidelines of BIO 2008, a global biotechnology event, on Wednesday.

The integrated facility will be located on 17.2ha in Rembia, Alor Gajah.

Melaka Biotech Holdings Sdn Bhd, the state government's biotechnology arm, will hold 20 per cent of Vivo Bio Malaysia in exchange for providing the land.

Vivo Bio Tech has a controlling 51 per cent, while the rest is held by Vanguard Creative Technologies Sdn Bhd, a firm owned by Datuk Chandrakant S.N. Avalani and his partners.

Vivo Bio Tech, Melaka Biotech and Vanguard exchanged the agreement documents at a ceremony witnessed by Science, Technology and Innovation Minister Datuk Dr Maximus J. Ongkili, Malacca Chief Minister Datuk Seri Ali Rustam and Malaysian Biotechnology Corp chief executive Datuk Iskandar Mizal Mahmood.

Meanwhile, Ali said Malacca has already secured foreign investments worth some US$2 billion (RM6.5 billion) this year, almost half of the amount received over the last seven years.

The interest is coming from biotechnology and manufacturing companies, he said.

"From 2000 to 2007, we attracted some US$4.8 billion (RM15.6 billion) of foreign direct investment," Ali said.

Malacca's yearly foreign investment target is RM3 billion.



Home | Biotech In Malaysia | About Us | One Stop Centre | The BioNexus Network | Grants & Programmes | Events |
Media Room
| Contact Us | Useful Links | Disclaimer